This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Finland, Ireland, Italy, Japan, Malta, Netherlands, New Zealand, Poland, United Kingdom, South Africa
The drug OXIS contains one active pharmaceutical ingredient (API):
|
1
Formoterol fumarate dihydrate
UNII W34SHF8J2K - FORMOTEROL FUMARATE
|
|
Formoterol is a predominantly selective β2-stimulator. Formoterol has bronchodilator activity in patients with reversible obstructive airway diseases. In humans formoterol is effective in the prophylaxis of bronchospasm induced by methacholine challenge. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| OXIS Inhalation powder | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| R03AC13 | Formoterol | R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AC Selective beta-2-adrenoreceptor agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8239P, 8240Q |
| Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 02143608, 02147003, 02159696, 02159710, 08510249, 08510261, 08859041, 08859058, 10090820, 10090837, 10249870, 10542305, 10730099, 10759068, 10828131 |
| Country: EE | Ravimiamet | Identifier(s): 1034064, 1034075 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61666, 61667 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 115904, 396080, 458677, 582556 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 139439, 139441, 147057, 147065, 162193, 162195, 32439, 32453, 374439, 375752 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 38946, 38989 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 033312024 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2259711G1024, 2259711G2020 |
| Country: MT | Medicines Authority | Identifier(s): MA046/02201, MA046/02202 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 14070235, 14070243 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 66478, 66486 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 7866 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100089600, 100213388 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): 32/10.2.1/0168 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
